Trial · NCT00623623
Outcomes25
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 25
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Patients With All-cause Mortality, Cardiogenic Shock, Congestive Heart Failure and Recurrent Myocardial Infarction Within 30 Days for FAS. | 30 days | Full analysis set (FAS): All consented patients either randomised by Interactive Voice Response System (IVRS) or treated (i.e., manually allocated to treatment group) by the investigator. This population is also referred to as the intention-to-treat population (ITT). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With All Cause Mortality | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Cardiac Mortality | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Cardiogenic Shock | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Congestive Heart Failure (CHF) | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Recurrent Myocardial Infarction (Reinfarction) | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Rehospitalisation for Cardiac Reasons | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Rehospitalisation for Non-cardiac Reasons | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Serious Repeat Target Vessel Revascularization | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With All Cause Death and Shock | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With All Cause Death and Shock and CHF | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With All Cause Death and Shock and Reinfarction | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Total Fatal Stroke | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Total Disabling Stroke | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Total Non-disabling Stroke | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Intracranial Haemorrhage | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Ischaemic Stroke | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Total Stroke (All Types) | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Major Non-intracranial Bleeds Including Blood Transfusions | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients With Minor Non-intracranial Bleeds | 30 days | FAS | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00623623/outcomes